Alpha Fetoprotein, Tumor Marker

Alpha-Fetoprotein, Tumor Marker 

CPT Code(s)

82105

Methodology

Immunoassay (IA)

Limitations

Patients who have received monoclonal mouse antibodies may have abnormal results. For any patient taking a high dose of biotin, the specimen should be drawn at least eight hours after the last dose.

Reference Range(s)

  Male (ng/mL) Female (ng/mL)
0.5-16387.00.5-18964.0
1-11 Months 0.5-28.3 0.5-77.0
1-3 Years 0.5-7.9 0.5-11.1
>3 Years <6.1 <6.1
*Pediatric range is based on full term neonates, values for premature infants may be higher.
The use of AFP as a tumor marker in pregnant females is not recommended.

 

Clinical Significance

Elevation of serum AFP above values found in healthy individuals occurs in several malignant diseases, most notably nonseminomatous testicular cancer and primary hepatocellular carcinoma. AFP is not recommended as a screening procedure to detect cancer in the general population.

Alternative Name(s)

AFP

Quest Test code 237

Alpha-Fetoprotein, Tumor Marker 

CPT Code(s)

82105

Methodology

Immunoassay (IA)

Limitations

Patients who have received monoclonal mouse antibodies may have abnormal results. For any patient taking a high dose of biotin, the specimen should be drawn at least eight hours after the last dose.

Reference Range(s)

  Male (ng/mL) Female (ng/mL)
0.5-16387.00.5-18964.0
1-11 Months 0.5-28.3 0.5-77.0
1-3 Years 0.5-7.9 0.5-11.1
>3 Years <6.1 <6.1
*Pediatric range is based on full term neonates, values for premature infants may be higher.
The use of AFP as a tumor marker in pregnant females is not recommended.

 

Clinical Significance

Elevation of serum AFP above values found in healthy individuals occurs in several malignant diseases, most notably nonseminomatous testicular cancer and primary hepatocellular carcinoma. AFP is not recommended as a screening procedure to detect cancer in the general population.

Alternative Name(s)

AFP

Please enter details below to search the lab nearest to you.